SyntheX
2016
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Accelerator/Inc
LATEST DEAL TYPE
6
INVESTORS
Description
Developer of a novel cell-based, synthetic biology-driven drug selection platform designed to provide efficient synthesis and identification of peptides and macrocycles. The company's platform discovers and designs drugs that target specific previously undruggable targets for therapeutic and biotechnological applications, enabling healthcare institutions to better serve human health.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 409 Illinois
- San Francisco, CA 94158
- United States
+1 (415) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore SyntheX’s full profile, request a free trial.
SyntheX Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 03-Jul-2018 | 00.00 | Completed | Pre-Clinical Trials | ||
| 3. Seed Round | 27-Apr-2017 | 00.000 | 00.00 | 000.00 | Completed | Pre-Clinical Trials |
| 2. Accelerator/Incubator | 27-Apr-2017 | $350K | Completed | Pre-Clinical Trials | ||
| 1. Accelerator/Incubator | 01-Mar-2016 | $350K | $350K | Completed | Product In Beta Test |
SyntheX Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
SyntheX Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| IDEAYA Biosciences | Formerly VC-backed | South San Francisco, CA | 00 | 00000 | 00000000 | 00000 |
| 000000 000000 | Venture Capital-Backed | South San Francisco, CA | 0 | 00.00 | 000000000000 | 00.00 |
| 0000000 0000000000 | Formerly VC-backed | Cambridge, United Kingdom | 00 | 00000 | 00000000 | 00000 |
| 000000 00000000000 | Venture Capital-Backed | Montreal, Canada | 00 | 00000 | 00000000000 | 00000 |
| 00000000000 000000 | Formerly VC-backed | Newark, CA | 00 | 00000 | 000000 - 000 | 00000 |
SyntheX Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| 8VC | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| JLABS | Accelerator/Incubator | 000 0000 | 000000 0 | |||
| Morgan Noble Healthcare Partners | PE/Buyout | Minority | 000 0000 | 000000 0 | ||
| Oriza Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| SOSV | Venture Capital | Minority | 000 0000 | 000000 0 |
SyntheX Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Maria Soloveychik Ph.D | Co-Founder, Chief Executive Officer & Board Member | ||
| Charly Chahwan | Co-Founder, Chief Scientific Officer & Board Member | ||
| Tri Luong | Head, Finance |